ExploreWatchlistsPricing
  1. JP-listed companies
  2. Eisai Co., Ltd.
  3. Financials
  4. Pretax margin (%)

Eisai Co., Ltd. (4523)

Market cap
¥1.24T
P/E ratio
22.9x
Eisai develops, manufactures and sells prescription drugs and over-the-counter medicines globally across Japan, North America, China, Europe and Asia.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndPretax margin (%) YoY (%)
Mar 31, 20261.6-79.74%
Mar 31, 20257.7-7.19%
Mar 31, 20248.3+37.84%
Mar 31, 20236-16.03%
Mar 31, 20227.2-11.48%
Mar 31, 20218.1-55.81%
Mar 31, 202018.4+32.30%
Mar 31, 201913.9+101.13%
Mar 31, 20186.9+41.45%
Mar 31, 20174.9-26.13%
Mar 31, 20166.6+139.93%
Mar 31, 20152.8-74.49%
Mar 31, 201410.8-5.37%
Mar 31, 201311.4-17.73%
Mar 31, 201213.9

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat